121 related articles for article (PubMed ID: 1554358)
1. Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells.
Evans GA; Wahl LM; Farrar WL
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):759-64. PubMed ID: 1554358
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
Terada N; Lucas JJ; Gelfand EW
J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
[TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.
DeCaprio JA; Furukawa Y; Ajchenbaum F; Griffin JD; Livingston DM
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1795-8. PubMed ID: 1531876
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion.
Ertesvag A; Engedal N; Naderi S; Blomhoff HK
J Immunol; 2002 Nov; 169(10):5555-63. PubMed ID: 12421932
[TBL] [Abstract][Full Text] [Related]
5. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the retinoblastoma gene product, RB, with cyclophilin A negatively affects cyclosporin-inhibited NFAT signaling.
Cui Y; Mirkia K; Florence Fu YH; Zhu L; Yokoyama KK; Chiu R
J Cell Biochem; 2002; 86(4):630-41. PubMed ID: 12210730
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma protein phosphorylation does not require activation of p34CDC2 protein kinase.
Evans GA; Farrar WL
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):965-9. PubMed ID: 1332690
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
Paliogianni F; Ahuja SS; Balow JP; Balow JE; Boumpas DT
J Immunol; 1993 Oct; 151(8):4081-9. PubMed ID: 8409387
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.
Szamel M; Bartels F; Resch K
Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.
Wang CY; Petryniak B; Thompson CB; Kaelin WG; Leiden JM
Science; 1993 May; 260(5112):1330-5. PubMed ID: 8493578
[TBL] [Abstract][Full Text] [Related]
13. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli].
Karitskaia IA; Aksenov ND; Zenin VV; Khaĭdukova AL; Marakhova II
Tsitologiia; 2006; 48(1):42-9. PubMed ID: 16568834
[TBL] [Abstract][Full Text] [Related]
14. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
16. Symmetry of the activation of cyclin-dependent kinases in mitogen and growth factor-stimulated T lymphocytes.
Modiano JF; Domenico J; Szepesi A; Terada N; Lucas JJ; Gelfand EW
Ann N Y Acad Sci; 1995 Sep; 766():134-48. PubMed ID: 7486650
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
[TBL] [Abstract][Full Text] [Related]
18. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
20. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
